Rajasthan Checks Cancer-Injection Supply After Two Vials Test Non-Sterile
The Rajasthan Medical Services Corporation (RMSCL) initiated checks on 2,770 cancer injections supplied to the state after two seized vials linked to the government cancer institute in Bikaner tested non-sterile.
Findings from the vial tests
Tests detected Escherichia coli (E. coli) in one vial and Serratia marcescens in the other. Both contained Avelumab, but at substantially lower levels than reference products.
Seizure and inquiry
Earlier in August 2026, the Delhi Police Crime Branch seized 22 vials of oncology and immunotherapy drugs, including Bavencio (Avelumab). Four vials were identified as intended for the Acharya Tulsi Regional Cancer Treatment and Research Institute in Bikaner. The Rajasthan Health Minister ordered an inquiry after high-cost cancer drugs meant for free supply to the hospital were allegedly recovered from Delhi’s black market.
Important Facts for Exams
- PD-L1 blockade: Avelumab is an IgG1 monoclonal antibody that binds PD-L1, blocking complexes that inhibit CD8+ T-cell responses.
- Maintenance use: Avelumab is approved as maintenance treatment for locally advanced or metastatic urothelial carcinoma that has not progressed after first-line platinum chemotherapy.
- Injectable contamination: Serratia marcescens has been implicated in contaminated injectables: a US nationwide recall followed its detection in pre-filled heparin-flush syringes.
- Intrinsic resistance: Serratia marcescens is intrinsically resistant to ampicillin, macrolides and first-generation cephalosporins, including cephalexin.